Clinical Trial Update: The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis

View source ↗

Summary

A retrospective database analysis comparing safety and effectiveness of dabigatran, rivaroxaban, and apixaban in Department of Defense patients with non-valvula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Apixaban (apixaban)
• Dabigatran (Dabigatran etexilate)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2019-06-03